# Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer

> **NCT03100136** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 7 (actual)

## Conditions studied

- Neuroinflammation

## Interventions

- **DRUG:** [11C]PF-06809247

## Key facts

- **NCT ID:** NCT03100136
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-16
- **Primary completion:** 2017-03-10
- **Final completion:** 2017-03-10
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03100136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03100136, "Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03100136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*